Gamamabs Pharma
FranceEntry
2021
Hold
5yr
Status
Active
Who owns Gamamabs Pharma?
Gamamabs Pharma is a French Biotech company, currently owned by Irdi Capital-Investissement since 2021 and iXO Private Equity.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Most recent investor
Irdi Capital-InvestissementIRDI Impulsion · 2021 · Buyout
2 ownership periods · full history below
Key facts
HQFrance
SectorBiotech
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2013 · present
iXO Private EquityActive
2013 · present(13yr) · FIP APL 2013 · 2013 · Growth
More from IRDI Impulsion
Other portfolio companies in the same fund.
More PE-backed in Biotech
Comparable biotech deals from other GPs.
USQuestions
Who owns Gamamabs Pharma?
Gamamabs Pharma is currently owned by Irdi Capital-Investissement and iXO Private Equity, through IRDI Impulsion, since 2021.
When did Irdi Capital-Investissement and 1 other acquire Gamamabs Pharma?
Irdi Capital-Investissement and 1 other acquired Gamamabs Pharma in 2021.
Who has owned Gamamabs Pharma over time?
Gamamabs Pharma has been through 2 private-equity ownership periods: iXO Private Equity · via FIP APL 2013 · since 2013; Irdi Capital-Investissement · via IRDI Impulsion · since 2021.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue